Kalshi tests pharma milestones with prediction markets on trials and approvals
Kalshi will start offering prediction-market bets on clinical trial outcomes and FDA regulatory decisions, selecting an initial set of markets with partner AppliedXL, signaling a move to apply market-based forecasting to biopharma and potentially provide new data-driven insights while aiming to manage risks in the field.